Correlation Between NRX Pharmaceuticals and Virax Biolabs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NRX Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRX Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRX Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on NRX Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRX Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRX Pharmaceuticals and Virax Biolabs.

Diversification Opportunities for NRX Pharmaceuticals and Virax Biolabs

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between NRX and Virax is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and NRX Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRX Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of NRX Pharmaceuticals i.e., NRX Pharmaceuticals and Virax Biolabs go up and down completely randomly.

Pair Corralation between NRX Pharmaceuticals and Virax Biolabs

Given the investment horizon of 90 days NRX Pharmaceuticals is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, NRX Pharmaceuticals is 1.76 times less risky than Virax Biolabs. The stock trades about -0.01 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  409.00  in Virax Biolabs Group on September 12, 2024 and sell it today you would lose (228.00) from holding Virax Biolabs Group or give up 55.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NRX Pharmaceuticals  vs.  Virax Biolabs Group

 Performance 
       Timeline  
NRX Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NRX Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Virax Biolabs Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NRX Pharmaceuticals and Virax Biolabs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NRX Pharmaceuticals and Virax Biolabs

The main advantage of trading using opposite NRX Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRX Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.
The idea behind NRX Pharmaceuticals and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.